ENOXAPARIN SODIUM | A205660 | SHENZHEN TECHDOW PHARMACEUTICAL CO LTD
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Citizen Petition from Kasowitz Benson Torres LLP on behalf of Adventapharma D... FDA-2024-P-0522 · 4 docket documents Kasowitz Benson Torres LLP on behalf of Adventapharma DWC LLC filed a citizen petition requesting that the FDA investigate and take appropriate actions against generic enoxaparin sodium injection (ANDA no. 205660) manufactured for NorthStar Rx by Shenzhen Techdow Pharmaceutical Co., Ltd., alleging t | 505(q) | 2024-01-26 | Open | Adventapharma DWC LLC |
Source: Regulations.gov. FDA citizen petitions matched by application number.
Highest NADAC/Unit
$11.81
per ml
Lowest NADAC/Unit
$7.13
per ml
Brand NDCs
0
Generic NDCs
7
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 81952013228ENOXAPARIN 120 MG/0.8 ML SYR | $11.81 | ML | Generic | — | 2026-06-17 |
| 81952013506ENOXAPARIN 150 MG/ML SYRINGE | $10.63 | ML | Generic | — | 2026-06-17 |
| 81952012323ENOXAPARIN 30 MG/0.3 ML SYR | $9.62 | ML | Generic | — | 2026-06-17 |
| 81952012424ENOXAPARIN 40 MG/0.4 ML SYR | $8.06 | ML | Generic | — | 2026-06-17 |
| 81952012626ENOXAPARIN 60 MG/0.6 ML SYR | $7.84 | ML | Generic | — | 2026-06-17 |
| 81952013006ENOXAPARIN 100 MG/ML SYRINGE | $7.37 | ML | Generic | — | 2026-06-17 |
| 81952012828ENOXAPARIN 80 MG/0.8 ML SYR | $7.13 | ML | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.